Get started
Depositary Receipt on PFIZER Issued by YUANTADepositary Receipt on PFIZER Issued by YUANTADepositary Receipt on PFIZER Issued by YUANTA

Depositary Receipt on PFIZER Issued by YUANTA

No trades
See on Supercharts
Overview Financials News Ideas
Discussions
Technicals Bonds

Depositary Receipt on PFIZER Issued by YUANTA forum


HaezeL
PFE not looking so good now lol. failed to breakout over 200 ema and now below 50 ema
nwoudwyk
PFE billions of dollars and the stock moves a few pennys sad
HaezeL
PFE Looking good so far, most likely will pull back a bit or go sideways under this 200 ema.
Snapshot
PFE a close above $25.24 today means we have broken the out of the daily bearish trend.
Snapshot
marijco
PFE let’s break this upward trendline!!! 🚀💉
HaezeL
PFE finally moving higher. approaching a major bearish trend line.
Snapshot
filip-c
PFE took my loss (-40% leveraged) on this one. Looks like it’s going down further
PFE Pfizer reported an 8% year-over-year drop in Q1 revenue, down to $13.7 billion—$370 million below expectations. However, adjusted earnings per share rose to $0.92, beating estimates by $0.24, thanks to strong cost management. COVID-related products continued to weigh on performance: Paxlovid sales plunged 76% year-over-year and missed forecasts, while Comirnaty jumped 62% and slightly exceeded projections. The company reaffirmed its 2025 revenue outlook of $61–$64 billion and adjusted EPS of $2.80–$3.00, though it cautioned that potential tariff effects haven't been factored in. Pfizer now targets $7.7 billion in cost reductions by 2027 through greater use of automation, AI, and streamlined processes.

After scrapping its obesity pill program over safety issues, Pfizer is looking at acquisitions to revive its cardiometabolic pipeline. The company faces long-term challenges including patent cliffs, regulatory threats from possible drug pricing changes, and waning investor confidence. Although it's cutting costs and investing in its R&D pipeline to steady the ship, Wall Street doubts Pfizer can replace the massive earnings it made during the COVID boom with new blockbuster drugs.
Snapshot
johnhs
PFE : not sure why pfe does not perform... i am owner of pfe. i enjoy the dividend but don't get why there is a buyers strike.

Fool makes sense... pfe has to fill the pipeline. bought alt & vktx as well today.